[1] Lind M, Boman K, Johansson L, et al. Thrombomodulin as a marker for bleeding complications during warfarin treatment[J].Arch Intern Med, 2009, 169: 1210-1215.
[2] Lind M, Boman K, Johansson L, et al. Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment[J]. J Intern Med, 2012, 271(3): 239-246.
[3] Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial[J]. Lancet, 2007, 370: 493-503.
[4] Oake N. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis[J]. CMAJ, 2007, 176: 1589-1594.
[5] 王斌, 徐志云, 叶小飞. 华人心脏机械瓣膜置换术后华法林抗凝强度标准的系统评价[J]. 国际心血管病杂志, 2010,37(6): 361-366.
[6] Lin M, Boman K, Johansson L, et al. D-dimer predicts major bleeding, cardiovascular events and all-cause mortality during warfarin treatment[J]. Clin Biochem, 2014, 47(7): 570-573.
